CME in Minutes: Education in Oncology & Hematology
Matthew R. Smith, MD, PhD - Combined Systemic Therapy to Combat Metastatic Hormone-Sensitive Prostate Cancer
22 Sep 2023
Please visit answersincme.com/WGA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses the role of triplet therapy for patients with metastatic hormone-sensitive prostate cancer. Upon completion of this activity, participants should be better able to: Discuss recommended, evidence-based triplet therapies for patients with metastatic hormone-sensitive prostate cancer (mHSPC); Recognize patient and disease factors that can guide the selection of triplet treatment strategies for mHSPC; and Explain how to minimize adverse events for patients being treated with triplet therapy for mHSPC.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana